53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
27.06.2022
We carried out a study evaluating potential uses of an AI-based cough detection system in northern Spain. Among enrolled participants there was a 71 year-old female with a history of smoking 20-40 cigarettes/day between ages 18to 36, and from age 67 to present. Past medical history revealed chronic non-productive cough, and several episodes of upper respiratory tract infections per year. She was enrolled in November 2020, when the AI system registered a mean cough frequency of 52 coughs/day. Following a quitting attempt in January 2021, she reported improvement in respiratory symptoms, which matched a reduction in cough frequency to 12 coughs/day.
This was sustained until April, when a smoking relapse increased cough frequency. Observing this contributed to her decision to stop smoking.
